These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1204 related items for PubMed ID: 10812736

  • 1. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ.
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ.
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.
    Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216
    [Abstract] [Full Text] [Related]

  • 4. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA, Meschievitz CK, Ballanco GA, Daum RS.
    Pediatrics; 1995 Apr 10; 95(4):522-7. PubMed ID: 7700752
    [Abstract] [Full Text] [Related]

  • 5. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C.
    P N G Med J; 2001 Apr 10; 44(1-2):6-16. PubMed ID: 12418673
    [Abstract] [Full Text] [Related]

  • 6. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.
    Pediatrics; 2006 Apr 10; 117(4):e717-24. PubMed ID: 16549502
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.
    Richie E, Punjabi NH, Harjanto SJ, Wangsasaputral F, Sukandar M, Supriatman M, Simanjuntak CH, Que JU, Cryz SJ.
    Vaccine; 1999 Mar 17; 17(11-12):1384-93. PubMed ID: 10195774
    [Abstract] [Full Text] [Related]

  • 8. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK, Anderson R, Cecchini D, Rost B, Griffin P, Benscoter K, Xu J, Montanez-Ortiz L, Siber GR.
    Dev Biol Stand; 1996 Mar 17; 86():283-96. PubMed ID: 8785957
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
    Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D, HibMenCY-TT 005 Study Group.
    Pediatr Infect Dis J; 2010 Jan 17; 29(1):48-52. PubMed ID: 20035207
    [Abstract] [Full Text] [Related]

  • 10. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr 17; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 11. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K.
    Int J Infect Dis; 2010 Jan 17; 14(1):e41-9. PubMed ID: 19467896
    [Abstract] [Full Text] [Related]

  • 12. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B.
    CMAJ; 1993 Oct 15; 149(8):1105-12. PubMed ID: 8221449
    [Abstract] [Full Text] [Related]

  • 13. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E.
    Int J Infect Dis; 2007 Nov 15; 11(6):488-95. PubMed ID: 17349809
    [Abstract] [Full Text] [Related]

  • 14. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Käyhty H.
    Lancet; 2007 Nov 15; 348(9043):1688-92. PubMed ID: 8973430
    [Abstract] [Full Text] [Related]

  • 15. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.
    Int J Infect Dis; 2008 May 15; 12(3):278-88. PubMed ID: 17981067
    [Abstract] [Full Text] [Related]

  • 16. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
    Goldblatt D, Richmond P, Millard E, Thornton C, Miller E.
    J Infect Dis; 1999 Aug 15; 180(2):538-41. PubMed ID: 10395878
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.
    J Am Geriatr Soc; 2004 Nov 15; 52(11):1883-7. PubMed ID: 15507066
    [Abstract] [Full Text] [Related]

  • 18. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L.
    Pediatr Infect Dis J; 2006 Aug 15; 25(8):706-12. PubMed ID: 16874170
    [Abstract] [Full Text] [Related]

  • 19. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, Poolman J, Boutriau D.
    Vaccine; 2007 Dec 12; 25(51):8487-99. PubMed ID: 17996996
    [Abstract] [Full Text] [Related]

  • 20. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
    Kurikka S, Käyhty H, Peltola H, Saarinen L, Eskola J, Mäkelä PH.
    Pediatrics; 1995 Jun 12; 95(6):815-22. PubMed ID: 7761204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.